122P - Different efficacy between two erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anaemia (CIA) treatment in patients with non-small...

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Supportive Care
Lung and other Thoracic Tumours
Presenter Analia Rodriguez Garzotto
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors A. Rodriguez Garzotto1, S. Cortijo2, C. Pernaut1, I. Otero1, G. Ruiz Ares1, L. Parrilla1, M. Blazquez Arroyo1, J. Zugazagoitia1, S. Ponce Aix1
  • 1Servicio De Oncologia Medica, University Hosptial 12 De Octubre Medical oncology, 28041 - Madrid/ES
  • 2Servicio Farmacia, University Hosptial 12 De Octubre Medical oncology, 28041 - Madrid/ES

Abstract

There are limited data on the relative effectiveness of biosimilar ESAs and other available ESAs for the treatment of CIA. In addition, it is unclear whether the most recent recommendations for more conservative use of ESAs to treat CIA are reflected in real-world clinical practice.